Since in cancer patients with ICI therapy IRAEs often occur within a timeframe of approximately 6 weeks after ICI therapy, we performed the final analysis for our study 50 days after tumor induction and 43 days after starting anti-PD-L1 therapy. The gene discussed is CD274; the disease is neoplasm.